Parvesh Kumar, MD

Joe and Jean Brandmeyer Chair and Professor of Radiation Oncology
Associate Director of Clinical Research, The University of Kansas Cancer Center
Radiation Oncologist
Radiation Oncology

Bachelor of Science, University of Kansas, Lawrence, KS
Doctor of Medicine, University of Kansas School of Medicine, Kansas City, KS
Intern, Thomas Jefferson University Hospital, Philadelphia, PA
Resident, Department of Radiation Oncology and Nuclear Medicine, Thomas Jefferson University Hospital, Philadelphia, PA


Curriculum vitae

In 2010, Parvesh Kumar, MD, returned to the University of Kansas Medical Center (KUMC) after graduating from medical school almost a quarter of a century ago to serve as the Joe and Jean Brandmeyer Chair and Professor of the Department of Radiation Oncology and the Associate Director of Clinical Research at The University of Kansas Cancer Center (KUCC).  Since his arrival, Dr. Kumar's accomplishments include: expanding from 2 to 11 Radiation Oncology Faculty members, adding 6 satellite facilities located throughout the Greater Kansas City Metro Area, development of a Physics Department that is spearheaded by the recruitment of a Chief of Physics, a complete renovation of the KUMC Richard and Annette Bloch Radiation Oncology Pavilion, and incorporating cutting-edge radiation therapy technology including Varian TrueBeamTM and GammaPod.   In his role as associate director of clinical research, Dr. Kumar is in charge of the Disease Working Groups, Chairs the Clinical Research Leadership Committee, and provides strategic direction and vision for the KUCC clinical research enterprise.

Dr. Kumar is internationally renowned for his contributions to the field of radiation therapy in the areas of lung cancer, head and neck tumors, and prostate cancer. He has been a principle investigator (PI) and co-PI on a wide variety of national (Cancer and Leukemia Group B and Radiation Therapy Oncology Group) and institutional clinical trials involving lung cancer, head and neck tumors and prostate cancer. He has also been the recipient of numerous federal and pharma industry research grants, including a current $1.22 million clinical trial award from the Department of Defense (DOD) for evaluating the role of docetaxel radiosensitization in high risk post-prostatectomy prostate cancer patients. Since 2005, Kumar has been named as one of the "Best Doctors in America."

Dr. Kumar came to the University of Kansas Medical Center and The University of Kansas Hospital from the University of Southern California Keck School of Medicine (USC KSOM) and Norris Cancer Center in Los Angeles, where he also served as professor and chair of the Department of Radiation Oncology from 2003 to 2010. During his 7 years at USC KSOM, Dr. Kumar rebuilt the Department of Radiation Oncology in the areas of clinical medicine, research and teaching. He doubled the Physics Faculty from 4 to 8 Ph.D. physicists, recruited several new clinical radiation oncologists and started the Los Angeles City-wide Mock Oral Board Examination for area residents from several institutions (University of California Irvine, University of California Los Angeles, Kaiser Permanente and Vantage Oncology). He also signifi­cantly increased the research portfolio of the Department, obtaining several pharma and federally funded grants.

Prior to USC KSOM, he was professor and first chair of the Department of Radiation Oncology at Robert Wood Johnson Medical School (RWJMS) in New Brunswick, NJ, where he also served as the associate cancer center direc­tor for Radiation Oncology at the Cancer Institute of New Jersey / RWJMS. While at RWJMS, he started the Academic Department of Radiation Oncology, expanding the program from 1 facility with 2 linear accelerators (Linacs) and 3 faculty members to eventually 3 facilities with a total of 6 Linacs and 10 total faculty members during the period from 1998 to 2003.

A Kansas City native, Kumar completed his Bachelor of Science degree in chemical engineering with honors from the University of Kansas. He received his Doctorate of Medicine degree from The University of Kansas School of Medicine, and completed his residency in radiation oncology at Thomas Jefferson University Hospital in Philadelphia, where he was Chief Resident and Fellow of the American Cancer Society in his senior year of training.
Last modified: Jan 06, 2014

Parvesh Kumar, MD

Contact

Parvesh Kumar, MD
Joe and Jean Brandmeyer Chair and Professor of Radiation Oncology
Associate Director of Clinical Research, The University of Kansas Cancer Center
Radiation Oncologist

Richard and Annette Bloch Radiation Oncology Pavilion, 3901 Rainbow Boulevard, MS 4033, Kansas City, KS 66160

P: 913-588-3600

ID=x6428